RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,181,179 shares; 2025Q1: 4,982,384 shares; 2025Q2: 4,982,384 shares; 2025Q3: 3,974,913 shares; 2025Q4: 3,356,782 shares; 2026Q1: 2,856,782 shares; 2026Q2: 2,965,160 shares; 2026Q3: 2,460,560 shares 2,460,560 $505M 16.61% -504,600 Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,161,801 shares; 2025Q1: 5,161,801 shares; 2025Q2: 5,502,710 shares; 2025Q3: 5,502,710 shares; 2025Q4: 5,502,710 shares; 2026Q1: 5,502,710 shares; 2026Q2: 3,872,052 shares; 2026Q3: 3,872,052 shares 3,872,052 $433M 14.24% 0 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,400,158 shares; 2025Q1: 8,827,712 shares; 2025Q2: 8,827,712 shares; 2025Q3: 8,827,712 shares; 2025Q4: 8,827,712 shares; 2026Q1: 8,650,158 shares; 2026Q2: 8,650,158 shares; 2026Q3: 8,650,158 shares 8,650,158 $203M 6.68% 0 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,751,284 shares; 2025Q1: 19,751,284 shares; 2025Q2: 19,751,284 shares; 2025Q3: 19,751,284 shares; 2025Q4: 19,751,284 shares; 2026Q1: 16,001,284 shares; 2026Q2: 16,001,284 shares; 2026Q3: 16,001,284 shares 16,001,284 $187M 6.16% 0 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,288,760 shares; 2025Q1: 2,740,141 shares; 2025Q2: 2,740,141 shares; 2025Q3: 2,740,141 shares; 2025Q4: 7,133,720 shares; 2026Q1: 7,133,720 shares; 2026Q2: 7,133,720 shares; 2026Q3: 6,227,034 shares 6,227,034 $155M 5.11% -906,686 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,276,595 shares; 2025Q4: 1,559,595 shares; 2026Q1: 2,559,595 shares; 2026Q2: 2,391,075 shares; 2026Q3: 2,134,007 shares 2,134,007 $129M 4.25% -257,068 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,000,000 shares; 2026Q2: 2,154,704 shares; 2026Q3: 2,847,100 shares 2,847,100 $115M 3.79% +692,396 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,657,096 shares; 2025Q4: 2,265,674 shares; 2026Q1: 2,547,557 shares; 2026Q2: 2,547,557 shares; 2026Q3: 3,608,968 shares 3,608,968 $93.8M 3.09% +1,061,411 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,944,194 shares; 2025Q1: 3,944,194 shares; 2025Q2: 3,944,194 shares; 2025Q3: 3,649,794 shares; 2025Q4: 2,127,665 shares; 2026Q1: 1,976,196 shares; 2026Q2: 1,476,196 shares; 2026Q3: 4,215,886 shares 4,215,886 $92.2M 3.03% +2,739,690 Timeline ZYME ZYMEWORKS INC More: the full row for ZYMEWORKS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,308,935 shares; 2025Q1: 4,308,935 shares; 2025Q2: 4,308,935 shares; 2025Q3: 3,938,641 shares; 2025Q4: 3,938,641 shares; 2026Q1: 3,734,142 shares; 2026Q2: 3,649,142 shares; 2026Q3: 3,464,142 shares 3,464,142 $91.8M 3.02% -185,000 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,750,683 shares; 2025Q1: 5,750,683 shares; 2025Q2: 5,750,683 shares; 2025Q3: 5,750,683 shares; 2025Q4: 5,750,683 shares; 2026Q1: 5,750,683 shares; 2026Q2: 5,750,683 shares; 2026Q3: 5,750,683 shares 5,750,683 $88.3M 2.9% 0 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,771,417 shares; 2025Q1: 1,771,417 shares; 2025Q2: 1,771,417 shares; 2025Q3: 3,203,917 shares; 2025Q4: 3,479,022 shares; 2026Q1: 3,459,358 shares; 2026Q2: 3,366,823 shares; 2026Q3: 2,691,426 shares 2,691,426 $84.2M 2.77% -675,397 Timeline PVLA PALVELLA THERAPEUTICS INC NE More: the full row for PALVELLA THERAPEUTICS INC NE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 696,555 shares; 2025Q1: 696,555 shares; 2025Q2: 696,555 shares; 2025Q3: 1,161,249 shares; 2025Q4: 879,009 shares; 2026Q1: 960,989 shares; 2026Q2: 672,789 shares; 2026Q3: 607,149 shares 607,149 $83.7M 2.75% -65,640 Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,567,469 shares; 2025Q1: 7,754,129 shares; 2025Q2: 7,754,129 shares; 2025Q3: 8,617,162 shares; 2025Q4: 8,617,162 shares; 2026Q1: 8,445,769 shares; 2026Q2: 8,445,769 shares; 2026Q3: 6,690,108 shares 6,690,108 $71.7M 2.36% -1,755,661 Timeline ACIU AC IMMUNE SA More: the full row for AC IMMUNE SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,522,436 shares; 2025Q1: 19,822,436 shares; 2025Q2: 19,822,436 shares; 2025Q3: 19,822,436 shares; 2025Q4: 19,822,436 shares; 2026Q1: 19,822,436 shares; 2026Q2: 19,822,436 shares; 2026Q3: 19,822,436 shares 19,822,436 $51.9M 1.71% 0 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,764,471 shares; 2025Q1: 5,660,132 shares; 2025Q2: 5,660,132 shares; 2025Q3: 5,660,132 shares; 2025Q4: 3,835,886 shares; 2026Q1: 4,460,886 shares; 2026Q2: 4,460,886 shares; 2026Q3: 4,276,578 shares 4,276,578 $51M 1.68% -184,308 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,425,000 shares; 2026Q3: 17,052,893 shares 17,052,893 $49.6M 1.63% +14,627,893 Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,715,893 shares; 2025Q1: 5,295,893 shares; 2025Q2: 5,295,893 shares; 2025Q3: 5,295,893 shares; 2025Q4: 5,295,893 shares; 2026Q1: 5,295,893 shares; 2026Q2: 5,295,893 shares; 2026Q3: 5,295,893 shares 5,295,893 $45.8M 1.51% 0 2026-10-14, 13D/A : 8,939,731 shares, 9.8% of the class, 13D/A filed 2026-10-16 Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,387,863 shares; 2025Q3: 1,387,863 shares; 2025Q4: 2,748,763 shares; 2026Q1: 2,748,763 shares; 2026Q2: 2,748,763 shares; 2026Q3: 3,093,590 shares 3,093,590 $45.1M 1.48% +344,827 Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,670,642 shares; 2025Q1: 4,561,289 shares; 2025Q2: 4,629,289 shares; 2025Q3: 4,629,289 shares; 2025Q4: 4,629,289 shares; 2026Q1: 2,879,289 shares; 2026Q2: 2,879,289 shares; 2026Q3: 2,879,289 shares 2,879,289 $41.2M 1.36% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,024,288 shares; 2025Q3: 1,574,288 shares; 2025Q4: 1,488,975 shares; 2026Q1: 1,294,463 shares; 2026Q2: 1,294,463 shares; 2026Q3: 1,230,909 shares 1,230,909 $37.3M 1.23% -63,554 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,000,000 shares; 2025Q1: 7,000,000 shares; 2025Q2: 7,000,000 shares; 2025Q3: 7,000,000 shares; 2025Q4: 9,128,080 shares; 2026Q1: 8,698,173 shares; 2026Q2: 8,698,173 shares; 2026Q3: 8,278,164 shares 8,278,164 $35M 1.15% -420,009 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,796,513 shares; 2025Q1: 2,796,513 shares; 2025Q2: 2,761,333 shares; 2025Q3: 1,495,290 shares; 2025Q4: 1,495,290 shares; 2026Q1: 1,584,727 shares; 2026Q2: 1,056,027 shares; 2026Q3: 407,226 shares 407,226 $34.8M 1.15% -648,801 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,500,000 shares; 2026Q3: 3,500,000 shares 3,500,000 $34.6M 1.14% +1,000,000 Timeline PYXS PYXIS ONCOLOGY INC More: the full row for PYXIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 11,826,140 shares 11,826,140 $27.6M 0.91% new Timeline ABSI ABSCI CORPORATION More: the full row for ABSCI CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,361,674 shares; 2026Q3: 2,361,674 shares 2,361,674 $25.4M 0.84% 0 Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,525,000 shares; 2026Q1: 19,525,000 shares; 2026Q2: 28,165,000 shares; 2026Q3: 28,165,000 shares 28,165,000 $24.5M 0.81% 0 Timeline AVR ANTERIS TECHNOLOGIES GLOBAL More: the full row for ANTERIS TECHNOLOGIES GLOBAL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 3,000,000 shares 3,000,000 $23.3M 0.77% 0 Timeline FHTX FOGHORN THERAPEUTICS INC More: the full row for FOGHORN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,302,000 shares; 2025Q1: 5,302,000 shares; 2025Q2: 5,302,000 shares; 2025Q3: 5,302,000 shares; 2025Q4: 5,302,000 shares; 2026Q1: 5,842,000 shares; 2026Q2: 5,842,000 shares; 2026Q3: 5,842,000 shares 5,842,000 $20.9M 0.69% 0 2026-10-01, 13G/A : 8,507,000 shares, 14.3% of the class, 13G/A filed 2026-10-05 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,251,788 shares; 2026Q2: 1,251,788 shares; 2026Q3: 1,251,788 shares 1,251,788 $20.2M 0.66% 0 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,350,000 shares; 2026Q3: 2,350,000 shares 2,350,000 $19.4M 0.64% 0 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,046,206 shares 10,046,206 $18.6M 0.61% new Timeline ELDN ELEDON PHARMACEUTICALS INC More: the full row for ELEDON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,293,282 shares; 2025Q1: 6,293,282 shares; 2025Q2: 6,293,282 shares; 2025Q3: 6,293,282 shares; 2025Q4: 6,293,282 shares; 2026Q1: 6,293,282 shares; 2026Q2: 6,293,282 shares; 2026Q3: 6,293,282 shares 6,293,282 $15.9M 0.52% 0 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 650,000 shares; 2026Q1: 1,272,312 shares; 2026Q2: 1,153,612 shares; 2026Q3: 233,300 shares 233,300 $15.3M 0.5% -920,312 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,036,679 shares; 2025Q1: 1,036,679 shares; 2025Q2: 1,028,049 shares; 2025Q3: 1,355,256 shares; 2025Q4: 1,355,257 shares; 2026Q1: 1,632,845 shares; 2026Q2: 2,075,545 shares; 2026Q3: 907,406 shares 907,406 $13.9M 0.46% -1,168,139 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,978,972 shares; 2026Q2: 3,235,778 shares; 2026Q3: 4,045,278 shares 4,045,278 $11M 0.36% +809,500 Timeline IMUX IMMUNIC INC More: the full row for IMMUNIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 765,295 shares; 2026Q3: 765,295 shares 765,295 $7.12M 0.23% 0 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $6.25M 0.21% new Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $5.92M 0.19% new Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $5.36M 0.18% 0 Timeline MOLN MOLECULAR PARTNERS AG More: the full row for MOLECULAR PARTNERS AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,353,968 shares; 2025Q1: 1,353,968 shares; 2025Q2: 1,353,968 shares; 2025Q3: 1,353,968 shares; 2025Q4: 1,353,968 shares; 2026Q1: 1,353,968 shares; 2026Q2: 1,353,968 shares; 2026Q3: 1,353,968 shares 1,353,968 $5.19M 0.17% 0 Timeline IMA IMAGENEBIO INC More: the full row for IMAGENEBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 802,102 shares; 2025Q4: 802,102 shares; 2026Q1: 1,110,002 shares; 2026Q2: 1,110,002 shares; 2026Q3: 1,110,002 shares 1,110,002 $5.08M 0.17% 0 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,233,742 shares; 2025Q4: 2,233,742 shares; 2026Q1: 2,233,742 shares; 2026Q2: 2,233,742 shares; 2026Q3: 1,576,624 shares 1,576,624 $4.57M 0.15% -657,118 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 686,040 shares; 2025Q1: 686,040 shares; 2025Q2: 686,040 shares; 2025Q3: 686,040 shares; 2025Q4: 686,040 shares; 2026Q1: 686,040 shares; 2026Q2: 686,040 shares; 2026Q3: 686,040 shares 686,040 $2.53M 0.08% 0 Timeline TCRX TSCAN THERAPEUTICS INC More: the full row for TSCAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,989,474 shares; 2025Q1: 4,889,474 shares; 2025Q2: 5,226,074 shares; 2025Q3: 5,226,074 shares; 2025Q4: 5,226,074 shares; 2026Q1: 5,564,290 shares; 2026Q2: 5,564,290 shares; 2026Q3: 5,564,290 shares 5,564,290 $1.75M 0.06% 0 Timeline ENGNW ENGENE THERAPEUTICS INC More: the full row for ENGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 945,402 shares; 2026Q3: 945,402 shares 945,402 $189K 0.01% 0 Timeline TENX TENAX THERAPEUTICS INC More: the full row for TENAX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 339,549 shares; 2025Q1: 339,549 shares; 2025Q2: 339,549 shares; 2025Q3: 339,549 shares; 2025Q4: 339,549 shares; 2026Q1: 339,549 shares; 2026Q2: 339,549 shares; 2026Q3: 25,000 shares 25,000 $47.2K <0.01% -314,549 Timeline